The Effect of Esketamine on Postoperative Pain Relief in Patients Undergoing Laparoscopic Surgery - Trial NCT06300944
Access comprehensive clinical trial information for NCT06300944 through Pure Global AI's free database. This phase not specified trial is sponsored by General Hospital of Ningxia Medical University and is currently Recruiting. The study focuses on Postoperative Pain. Target enrollment is 108 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
General Hospital of Ningxia Medical University
Timeline & Enrollment
N/A
Dec 01, 2023
Oct 01, 2024
Primary Outcome
Moderate to severe pain,Incidence of adverse reactions including nausea, vomiting and dizziness,Sleep quality
Summary
The purpose of this study is to investigate whether continuous intraoperative infusion of
 esketamine combined with the addition of esketamine to postoperative PCIA can improve
 postoperative pain and sleep quality in patients undergoing laparoscopic uterine surgery
 under general anesthesia.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06300944
Non-Device Trial